Literature DB >> 27633452

Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.

C Joaquín Cáceres1, Jenniffer Angulo1, Nataly Contreras1, Karla Pino1, Jorge Vera-Otarola1, Marcelo López-Lastra2.   

Abstract

Replication of the human immunodeficiency virus type 1 (HIV-1) is dependent on eIF5A hypusination. Hypusine is formed post-translationally on the eIF5A precursor by two consecutive enzymatic steps; a reversible reaction involving the enzyme deoxyhypusine synthase (DHS) and an irreversible step involving the enzyme deoxyhypusine hydroxylase (DOHH). In this study we explored the effect of inhibiting DOHH activity and therefore eIF5A hypusination, on HIV-1 gene expression. Results show that the expression of proteins from an HIV-1 molecular clone is reduced when DOHH activity is inhibited by Deferiprone (DFP) or Ciclopirox (CPX). Next we evaluated the requirement of DOHH activity for internal ribosome entry site (IRES)-mediated translation initiation driven by the 5'untranslated region (5'UTR) of the full length HIV-1 mRNA. Results show that HIV-1 IRES activity relies on DOHH protein concentration and enzymatic activity. Similar results were obtained for IRES-dependent translation initiation mediated by 5'UTR of the human T-cell lymphotropic virus type 1 (HTLV-1) and the mouse mammary tumor virus (MMTV) mRNAs. Interestingly, activity of the poliovirus IRES, was less sensitive to the targeting of DOHH suggesting that not all viral IRESs are equally dependent on the cellular concentration or the activity of DOHH. In summary we present evidence indicating that the cellular concentration of DOHH and its enzymatic activity play a role in HIV-1, HTLV-1 and MMTV IRES-mediated translation initiation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DOHH; HIV-1; HTLV-1 MMTV; IRES; Protein synthesis; RNA; eIF5A

Mesh:

Substances:

Year:  2016        PMID: 27633452     DOI: 10.1016/j.antiviral.2016.09.006

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  16 in total

1.  A new non-radioactive deoxyhypusine synthase assay adaptable to high throughput screening.

Authors:  Myung Hee Park; Ajeet Mandal; Swati Mandal; Edith C Wolff
Journal:  Amino Acids       Date:  2017-08-17       Impact factor: 3.520

2.  KRAS Oncoprotein Expression Is Regulated by a Self-Governing eIF5A-PEAK1 Feed-Forward Regulatory Loop.

Authors:  Ken Fujimura; Huawei Wang; Felicia Watson; Richard L Klemke
Journal:  Cancer Res       Date:  2018-01-10       Impact factor: 12.701

3.  The double-stranded RNA-binding protein, Staufen1, is an IRES-transacting factor regulating HIV-1 cap-independent translation initiation.

Authors:  Hade Ramos; Anne Monette; Meijuan Niu; Aldo Barrera; Brenda López-Ulloa; Yazmín Fuentes; Paola Guizar; Karla Pino; Luc DesGroseillers; Andrew J Mouland; Marcelo López-Lastra
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

Review 4.  Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

Authors:  George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

Review 5.  Translational Control in Virus-Infected Cells.

Authors:  Noam Stern-Ginossar; Sunnie R Thompson; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

Review 6.  Reposition of the Fungicide Ciclopirox for Cancer Treatment.

Authors:  Zhu Huang; Shile Huang
Journal:  Recent Pat Anticancer Drug Discov       Date:  2021       Impact factor: 3.038

Review 7.  Insights into Structural and Mechanistic Features of Viral IRES Elements.

Authors:  Encarnacion Martinez-Salas; Rosario Francisco-Velilla; Javier Fernandez-Chamorro; Azman M Embarek
Journal:  Front Microbiol       Date:  2018-01-04       Impact factor: 5.640

8.  Non-canonical translation initiation of the spliced mRNA encoding the human T-cell leukemia virus type 1 basic leucine zipper protein.

Authors:  C Joaquín Cáceres; Jenniffer Angulo; Fernando Lowy; Nataly Contreras; Beth Walters; Eduardo Olivares; Delphine Allouche; Anne Merviel; Karla Pino; Bruno Sargueil; Sunnie R Thompson; Marcelo López-Lastra
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

9.  Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly.

Authors:  Jung-Ah Kang; Songwon Kim; Minji Park; Hyun-Jin Park; Jeong-Hyun Kim; Sanghyeok Park; Jeong-Ryul Hwang; Yong-Chul Kim; Yoon Jun Kim; Yuri Cho; Mi Sun Jin; Sung-Gyoo Park
Journal:  Nat Commun       Date:  2019-05-16       Impact factor: 14.919

10.  Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli.

Authors:  Zachary C Conley; Kimberly M Carlson-Banning; Ashley G Carter; Alejandro de la Cova; Yongcheng Song; Lynn Zechiedrich
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.